To validate whether the above anti-proliferative effect was produced by interaction of EGFR protein and the synthesized compounds, the synthesized compounds were evaluated for their abilities to inhibit the activity of four protein kinases relevant to cancer: EGFR, VEGFR2, bFGF, PDGFR. Here, PDGFRB is linked to cancer.